← Leaderboards
Niklaus Hoyt Evitt
University Of Pennsylvania
$94,662
Attributed
$94,662
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2020–21$100K$75K$50K$25K$0
'20
'21
Funding mix
By agency
NIH$94,662 · 1
By mechanism
F30$94,662 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Kiran Musunuru$21,648,838
- Samuel I. Parry$10,406,015
- Stephen G Emerson$28,932,839
- Marisa S. Bartolomei$30,824,670
- Rahul Manu Kohli$12,428,397
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsBaseBenignBindingBioethicsBiologicalBiotechnologyBisulfite SequencingCatalystCell LineCellsChimeric ProteinsClustered Regularly Interspaced Short Palindromic RepeatsCodeCrispr/Cas TechnologyCustomCytosineDeep SequencingDemethylationDiagnosticDirected Molecular EvolutionDiscipline Of ObstetricsDistalActive Sites